Nephrology Doctors in Ft Collins, CO Accepting Medicare

3 Nephrology doctors found. Showing 1 - 3

Richard Edward Simmons, M.D. Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 1600 Specht Point Rd, Suite 127, Ft Collins, CO 80525 Phone: 970-493-7733    Fax: 970-493-8745

James Singer, M.D. Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 1600 Specht Point Rd, Suite 127, Ft Collins, CO 80525 Phone: 970-493-7733    Fax: 970-493-8745

Thomas Arthur Haygood, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1600 Specht Point Rd, Suite I, Ft Collins, CO 80525 Phone: 970-493-7733    Fax: 970-493-8745

News Archive

Link found between Alzheimer's disease biomarkers in healthy adults

A study published in the November issue of the Journal of Alzheimer's Disease provides an insight into normal, physiological levels and association between proteins involved in development of Alzheimer's disease.

Proteins involved in fragile X syndrome identified

The interplay of two proteins that bind to messenger RNA, a molecule that mediates translation of the information encoded in genes into proteins, triggers the appearance of fragile X-associated tremor/ataxia syndrome (FTAX), a late-life disorder associated with the gene that causes fragile X syndrome in children, said researchers from Baylor College of Medicine in Houston and Emory University School of Medicine in a report that appears today in the journal Neuron.

Addressing social needs in health care delivery can help achieve better health outcomes

Addressing social needs as a part of health care delivery can help achieve better health outcomes and potentially address major challenges in the United States health care system, according to a recently published consensus report by the National Academies of Sciences, Engineering and Medicine.

Gene variants and beta-blockers associated with increased risk of death

Patients with certain gene variants who were prescribed beta-blocker drugs after acute coronary syndrome (ACS) had an increased risk of death over the next three years, according to a study in the September 28 issue of Journal of the American Medical Association (JAMA).

Read more Medical News

› Verified 3 days ago